GSK’s Arexvy Vaccine Approved By UK Health Regulator for Respiratory Syncytial Virus (RSV)
United Kingdom’s health regulator has approved Arexvy, a GSK vaccine designed to fight the respiratory syncytial virus (RSV). This virus is responsible for causing many hospitalizations and fatalities every year, ...
